Biostatistics Professor Wei Pan has been given the University’s highest recognition of health-related research — membership in the Academy for Excellence in Health Research.
Professor Joseph Koopmeiners explains how the typical three-phase clinical trial works and the ways researchers and the FDA are safely speeding up the development of COVID-19 vaccines.
A global clinical trial in hospitalized patients is looking for answers.
Professors Baolin Wu and Jim Pankow are leading a new study to identify the segments of human genetic code associated with the onset of diabetes.
Biostatistician and Assistant Professor Mark Fiecas is co-leading a study looking at the emergence of depression and suicide risk in thousands of adolescents and how it relates to the behavior of specific brain regions over time.
School of Public Health and Medical School researchers are conducting two new studies to see if losartan can protect the lungs of COVID-19 patients.
The study co-authored by Associate Professor Kyle Rudser revealed increased stiffness in the abdominal aorta in children exposed to secondhand smoke.
The study co-led by Professor John Connett revealed no beneficial effect of beta blockers on the overall risk of exacerbations and strong evidence that using the drug was associated with severe exacerbations requiring hospitalization.
The project is led by Professor Haitao Chu and will create tools to aid medical researchers and decision-makers in understanding the benefits and risks of different diagnostic or treatment options.
This past June, PhD student Adam Kaplan traveled to Kampala, Uganda to teach data analysis software classes at the “UMN Hub” in Mulago hospital.
Assistant Professor Eric Lock is developing a method that will allow researchers to analyze different kinds of cancer and molecular cell data together.
Daynamica was co-developed by Associate Professor Julian Wolfson and captures detailed activity and travel information when people are driving, walking, biking, or using mass transit, such as riding a bus.